Evaluation of Sedation in COVID-19 ARDS

Status Completed

Clinical Trial Summary

This study focuses on the evaluation of various factors repeatedly discussed in relation to the impaired sedation of intubated ventilated COVID-19 patients. The sedation response of >100 moderately to severely affected COVID-19 ARDS was evaluated. The sedation level was measured at the bedside using the Richmond Agitation and Sedation Scale and ventilator synchrony. The evaluation was performed according to the static evaluation plan with respect to age, storage therapy and organ failure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hypnotics and Sedatives
Prone Position
Pulmonary Ventilation
Severe Acute Respiratory Syndrome
Severe Acute Respiratory Syndrome Coronavirus 2

Clinical Trial Details

NCT number	NCT04667936
Study type	Observational
Source	Goethe University
Contact
Status	Completed
Phase
Start date	March 1, 2020
Completion date	April 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05543616` - A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children	Phase 2/Phase 3
Recruiting	`NCT04516811` - Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19	Phase 3
Completed	`NCT04334044` - Treatment of SARS Caused by COVID-19 With Ruxolitinib	Phase 1/Phase 2
Terminated	`NCT04371978` - Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19	Phase 3
Recruiting	`NCT04466241` - Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial	Phase 2/Phase 3
Withdrawn	`NCT04381923` - COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia	N/A
Recruiting	`NCT04402879` - CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals	N/A
Recruiting	`NCT04661631` - Surgery and Lung Ultrasound in COVID-19 Infection
Completed	`NCT04376476` - Host-pathogen Interactions During SARS-CoV-2 Infection	N/A
Completed	`NCT04375098` - Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection	Phase 2
Completed	`NCT04402060` - A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19	Phase 1/Phase 2
Active, not recruiting	`NCT04365101` - Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19	Phase 1/Phase 2
Completed	`NCT04354779` - Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.
Recruiting	`NCT04367207` - African Covid-19 Critical Care Outcomes Study
Terminated	`NCT04409873` - Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)	Phase 2
Completed	`NCT04602351` - Communication in ICU During COVID-19
Terminated	`NCT04707703` - Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis	Phase 3
Active, not recruiting	`NCT04987528` - Pulmonary Fibrosis During Severe COVID-19 Pneumonia
Completed	`NCT04423770` - COVID-19 Related Health and Infection Control Practices Among Dentists
Completed	`NCT04379037` - Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients	N/A